Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.65
Delayed Data
As of Apr 24
 -0.0144 / -2.17%
Today’s Change
0.60
Today|||52-Week Range
3.27
-9.05%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.66
Today’s open0.67
Day’s range0.65 - 0.67
Volume323,162
Average volume (3 months)1,100,556
Market cap$14.3M
Dividend yield--
Data as of 04/24/2017

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+1.22%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
CBMXCombiMatrix Corp+0.10+2.08%
IGCIndia Globalization ...+0.01+2.88%
TENXTenax Therapeutics I...-0.01-1.14%
CLSNCelsion Corp-0.00-1.69%
Data as of 04/24/2017

Financials

Next reporting dateMay 18, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts


Search for Jobs